MetaVia announces 1-for-11 reverse stock split effective Dec 4, 2025 to meet Nasdaq listing requirements

MetaVia Inc.

Reverse split at 1-for-11 ratio effective 5:00 p.m. ET Dec 4, 2025; begins split-adjusted trading Dec 5.
Outstanding shares reduced from ~25.4 million to ~2.3 million; authorized shares unchanged at 100 million.
Options, RSUs, and warrants adjusted proportionately; fractional shares rounded down for cash payment.
Approved by stockholders on June 30, 2025; board set ratio; new CUSIP 64132R 503; symbol remains MTVA.
MetaVia is a clinical-stage biotech focused on cardiometabolic diseases; no financial results reported.

item 3.03 item 5.03 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MetaVia Inc.: Amendment to Certificate of Incorporation to effect a 1-for-11 reverse stock split of common stock (effective 2025-12-04).

Change: charter amendment
Effective: 2025-12-04

Exact text from the filing

On December 2, 2025, the Company filed with the Secretary of State of the State of Delaware (the “Delaware Secretary of State”) a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.

View on SEC.gov

Browse all governance changes →

MetaVia Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-117540

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.